Back to User profile » Dr Mingyue Shi
Papers published by Dr Mingyue Shi:
Screening of a Prognostic Gene Signature for Relapsed/Refractory Acute Myeloid Leukemia Based on Altered Circulating CircRNA Profiles
Guo H, Cui Y, Bai Y, Yan F, Zhang W, Chen Y, Shi M
International Journal of General Medicine 2024, 17:2967-2979
Published Date: 8 July 2024
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Newly Diagnosed Acute Myeloid Leukaemia Patients
Dou L, Shi M, Song J, Niu X, Niu J, Wei S, Li D, Bai Y, Sun K
Cancer Management and Research 2022, 14:303-316
Published Date: 25 January 2022
Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia
Pei Y, Shi M, Song J, Niu X, Wei S, Dou L, Xiao M, Li D, Xu F, Bai Y, Sun K
Cancer Management and Research 2021, 13:4135-4146
Published Date: 21 May 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study
Yang X, Bai Y, Shi M, Zhang W, Niu J, Wu C, Zhang L, Xu Z, Liu X, Chen Y, Sun K
Cancer Management and Research 2020, 12:1293-1301
Published Date: 20 February 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
Shi M, Xu F, Yang X, Bai Y, Niu J, Drokow EK, Chen M, Chen Y, Sun K
Cancer Management and Research 2019, 11:8229-8238
Published Date: 6 September 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Circulating microRNA as diagnostic biomarkers for haematological cancers: a systematic review and meta-analysis
Drokow EK, Sun K, Ahmed HAW, Akpabla GS, Song J, Shi M
Cancer Management and Research 2019, 11:4313-4326
Published Date: 10 May 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis
Drokow EK, Ahmed HAW, Amponsem-Boateng C, Akpabla GS, Song J, Shi M, Sun K
Therapeutics and Clinical Risk Management 2019, 15:637-646
Published Date: 6 May 2019